127 filings
Page 4 of 7
6-K
ddv 7lm2r
31 Mar 21
Mereo BioPharma Reports Full Year 2020 Financial Results and Recent Highlights
5:13pm
6-K
7y2nrlwq5v69i
12 Feb 21
Current report (foreign)
4:06pm
6-K
mruglm9lv
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
6-K
8jtkc e4v3tfw21q520
1 Feb 21
Current report (foreign)
5:06pm
6-K
gzxz5p49
14 Jan 21
Current report (foreign)
7:06am
6-K
re9m8jbhyph8o1j
17 Dec 20
Mereo BioPharma and Ultragenyx Announce Collaboration and License
5:16pm
6-K
sy7kbek9ps44j9yefi
15 Dec 20
Current report (foreign)
2:22pm
6-K
wjsaoo
16 Nov 20
Current report (foreign)
7:27am
6-K
zupk fg8mvtdql
12 Nov 20
Current report (foreign)
6:15am
6-K
64vytep8964hj 3xr
20 Oct 20
Mereo BioPharma Appoints Christine Fox as Chief Financial Officer and Heidi Petersen as Senior Vice President, Regulatory Affairs
7:12am
6-K
cqvv5mz7vtj9o87x
19 Oct 20
Current report (foreign)
8:10am
6-K
lvtlj77b yqyq
13 Oct 20
Current report (foreign)
8:00am
6-K
rsatx1cd2q k0cb
9 Oct 20
Current report (foreign)
4:05pm
6-K
bhc2axu tt
7 Oct 20
Mereo BioPharma Files Registration Statement on Form F-3 with U.S. Securities and Exchange Commission
9:53am
6-K
9ibdqbtybuup1ql wb
1 Oct 20
Current report (foreign)
4:30pm
6-K
cbqjandtws9o4d
29 Sep 20
Current report (foreign)
7:08am
6-K
swe1impr 1u
28 Sep 20
Result of General Meeting
4:43pm
6-K
2uozq1
28 Sep 20
Mereo BioPharma Announces Changes to Board of Directors
8:08am
6-K
1pttd1
24 Sep 20
Mereo BioPharma Receives FDA Rare Pediatric Disease Designation for Setrusumab for the Treatment of Osteogenesis Imperfecta
8:48am
6-K
9oju7il
4 Sep 20
Current report (foreign)
7:00am